Abstract
Cervical carcinoma is the main cause of cancer-related mortality in women and is correlated with more than 15 risk cofactors, including infection of cervical cells with high-risk types of HPV (hrHPV). Indeed, both aberrant methylation of the RASSF1A promoter and hrHPV infection are often observed in cervical carcinomas. The purpose of our meta-analysis was to evaluate the role of RASSF1A promoter methylation and hrHPV infection in cervical cancer. Our meta-analysis involved 895 cervical cancer patients and 454 control patients from 15 studies. Our results suggested that RASSF1A promoter hypermethylation increased the risk of cervical cancer (OR=9.77, 95%CI=[3.06, 31.26], P=0.0001, I2=78%). By grouping cases according to cancer subtypes, we found that HPV infection was higher in cervical squamous cell carcinomas (SCCs) than in cervical adenocarcinomas/ adenosquamous cancers (ACs/ASCs) (OR=4.00, 95%CI=[1.41, 11.30], P=0.009, I2=55%). Interestingly, HPV infection tended to occur in cervical cancers with relatively low levels of RASSF1A promoter methylation (OR=0.59, 95%CI=[0.36, 0.99], P=0.05, I2=0%). Our study provides evidence of a possible interaction between HPV infection and RASSF1A promoter methylation in the development of ...Continue Reading
References
Dec 21, 1990·Cell·M ScheffnerP M Howley
May 15, 1986·Nature·A P Bird
Jun 7, 1995·Journal of the National Cancer Institute·F X BoschK V Shah
May 1, 1994·Trends in Microbiology·A J Farthing, K H Vousden
Aug 19, 1999·The Journal of Pathology·J M WalboomersN Muñoz
May 25, 2002·Molecular and Cellular Biology·Latha ShivakumarMichael A White
Feb 7, 2003·The New England Journal of Medicine·Nubia MuñozUNKNOWN International Agency for Research on Cancer Multicenter Cervical Cancer Study Group
Apr 4, 2003·International Journal of Cancer. Journal International Du Cancer·Mei Y YuKai F To
Jun 16, 2004·Gynecologic Oncology·Tak-Hong CheungYick-Fu Wong
May 4, 2005·Cancer Research·Angelo AgathanggelouFarida Latif
Nov 14, 2006·Gynecologic Oncology·Hung-Cheng LaiTang-Yuan Chu
Sep 2, 2008·Gynecologic Oncology·Xavier Castellsagué
Jul 12, 2012·Oncology Letters·Abhimanyu Kumar JhaJagdeep Kaur
Feb 11, 2014·Nature Genetics·Xiaofan ZhuQian-Fei Wang
May 9, 2014·PloS One·Danjie JiangShiwei Duan
Aug 2, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Lei FengJian Tang
Citations
Nov 7, 2015·SpringerPlus·Chieko MishimaShinzaburo Noguchi
Apr 20, 2017·Biochemical Genetics·Joanna Katarzyna StrzelczykZofia Ostrowska
Nov 5, 2019·Journal of Cellular Biochemistry·Chunxiao LiJingjing Su
Jan 23, 2020·Cancers·Lucía García-GutiérrezDavid Matallanas
Aug 28, 2020·Frontiers in Oncology·Susana Romero-GarciaAngeles Carlos-Reyes
Dec 31, 2017·Archives of Gynecology and Obstetrics·Fei Zheng, Huimin Yu
Mar 6, 2017·Oncology Reports·Fufen YinYankui Wang
Jan 21, 2016·Toxicology Research·Di LiuAi Gao
Dec 6, 2019·Frontiers in Genetics·Shiqi HuangChunxia Jing
Sep 18, 2020·Pathogens and Disease·Saman SaadatMohammad Yousef Alikhani
May 27, 2021·The Journal of International Medical Research·Jing-Hang MaZhen Feng